Recent studies revealed kallikrein 11 expression in prostate and breast cancer cell lines and in ovarian, prostate, breast, lung, pancreatic, colon, and neuroendocrine cancer tissue (39-41). Here, KLK11 is linked to neuroendocrine carcinoma.